Murphy Kaitlin C, Whitehead Jacklyn, Zhou Dejie, Ho Steve S, Leach J Kent
Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA.
Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616, USA; Department of Orthopaedic Surgery, UC Davis Health, Sacramento, CA 95817, USA.
Acta Biomater. 2017 Dec;64:176-186. doi: 10.1016/j.actbio.2017.10.007. Epub 2017 Oct 5.
Mesenchymal stem cells (MSCs) secrete endogenous factors such as vascular endothelial growth factor (VEGF) and prostaglandin E2 (PGE) that promote angiogenesis, modulate the inflammatory microenvironment, and stimulate wound repair, and MSC spheroids secrete more trophic factors than dissociated, individual MSCs. Compared to injection of cells alone, transplantation of MSCs in a biomaterial can enhance their wound healing potential by localizing cells at the defect site and upregulating trophic factor secretion. To capitalize on the therapeutic potential of spheroids, we engineered a fibrin gel delivery vehicle to simultaneously enhance the proangiogenic and anti-inflammatory potential of entrapped human MSC spheroids. We used multifactorial statistical analysis to determine the interaction between four input variables derived from fibrin gel synthesis on four output variables (gel stiffness, gel contraction, and secretion of VEGF and PGE). Manipulation of the four input variables tuned fibrin gel biophysical properties to promote the simultaneous secretion of VEGF and PGE by entrapped MSC spheroids while maintaining overall gel integrity. MSC spheroids in stiffer gels secreted the most VEGF, while PGE secretion was highest in more compliant gels. Simultaneous VEGF and PGE secretion was greatest using hydrogels with intermediate mechanical properties, as small increases in stiffness increased VEGF secretion while maintaining PGE secretion by entrapped spheroids. The fibrin gel formulation predicted to simultaneously increase VEGF and PGE secretion stimulated endothelial cell proliferation, enhanced macrophage polarization, and promoted angiogenesis when used to treat a wounded three-dimensional human skin equivalent. These data demonstrate that a statistical approach is an effective strategy to formulate fibrin gel formulations that enhance the wound healing potential of human MSCs.
Mesenchymal stem cells (MSCs) are under investigation for wound healing applications due to their secretion of bioactive factors that enhance granulation tissue formation, blood vessel ingrowth, and reduce inflammation. However, the effectiveness of cell-based therapies is reduced due to poor engraftment and high rates of cell death when transplanted into harsh environments characteristic of large wounds. Compared to dissociated cells, MSCs exhibit increased overall function when aggregated into three-dimensional spheroids, and transplantation of cells using biomaterials is one strategy for guiding cell function in the defect site. The present study demonstrates that the biophysical properties of fibrin hydrogels, designed for use as a cell carrier, can be engineered to dictate the secretion of bioactive factors by entrapped MSC spheroids. This strategy enables MSCs to contribute to wound healing by synergistically promoting neovascularization and modulating the inflammatory milieu.
间充质干细胞(MSCs)分泌诸如血管内皮生长因子(VEGF)和前列腺素E2(PGE)等内源性因子,这些因子可促进血管生成、调节炎症微环境并刺激伤口修复,并且MSC球体比分离的单个MSCs分泌更多的营养因子。与单独注射细胞相比,将MSCs移植到生物材料中可通过将细胞定位在缺损部位并上调营养因子分泌来增强其伤口愈合潜力。为了利用球体的治疗潜力,我们设计了一种纤维蛋白凝胶递送载体,以同时增强包裹的人MSC球体的促血管生成和抗炎潜力。我们使用多因素统计分析来确定纤维蛋白凝胶合成中四个输入变量与四个输出变量(凝胶硬度、凝胶收缩以及VEGF和PGE的分泌)之间的相互作用。对四个输入变量的操作调整了纤维蛋白凝胶的生物物理特性,以促进包裹的MSC球体同时分泌VEGF和PGE,同时保持凝胶的整体完整性。在较硬凝胶中的MSC球体分泌的VEGF最多,而在更柔软的凝胶中PGE分泌最高。使用具有中等机械性能的水凝胶时,VEGF和PGE的同时分泌量最大,因为硬度的小幅增加会增加VEGF分泌,同时保持包裹球体的PGE分泌。预测可同时增加VEGF和PGE分泌的纤维蛋白凝胶制剂在用于治疗三维人皮肤等效物伤口时,可刺激内皮细胞增殖、增强巨噬细胞极化并促进血管生成。这些数据表明,统计方法是制定增强人MSCs伤口愈合潜力的纤维蛋白凝胶制剂的有效策略。
间充质干细胞(MSCs)因其分泌的生物活性因子可增强肉芽组织形成、血管长入并减轻炎症,而正在被研究用于伤口愈合应用。然而,当移植到大型伤口特有的恶劣环境中时,基于细胞的疗法的有效性会因植入不佳和细胞死亡率高而降低。与分离的细胞相比,MSCs聚集成三维球体时整体功能增强,并且使用生物材料移植细胞是在缺损部位引导细胞功能的一种策略。本研究表明,设计用作细胞载体的纤维蛋白水凝胶的生物物理特性可以被设计成决定包裹的MSC球体生物活性因子的分泌。这种策略使MSCs能够通过协同促进新血管形成和调节炎症环境来促进伤口愈合。